Skip to main content
. 2007 Oct 17;45(12):4011–4017. doi: 10.1128/JCM.01343-07

TABLE 2.

Performance of Clearview Chlamydia MF (relative to PCR) with CS and VS specimens at the SHC in Iloilo Citya

Yr Total no. tested Sample type Sensitivity (%), 95% CI Specificity (%), 95% CI PPV (%), 95% CI NPV (%), 95% CI
2002 397 CS 56.2 (41/73), 44.8-67.6 99.4 (322/324), 98.5-100 95.4 (41/43), 89.1-100 91.2 (322/353), 88.3-94.2
2004 425 CS 51.2 (44/86), 40.6-61.7 98.8 (335/339), 97.7-100 91.7 (44/48), 83.9-99.5 88.9 (335/377), 85.7-92.0
Total 822 CS 53.5 (85/159), 45.7-61.2 99.1 (657/663), 98.4-99.8 93.4 (85/91), 88.3-98.5 90.0 (657/730), 87.8-92.2
2002 196 SCVS 25.0 (9/36), 10.9-39.2 93.8 (150/160), 90.0-97.5 47.4 (9/19), 24.9-69.8 84.7 (150/177), 79.4-90.0
2004 137 CCVS 40.0 (10/25), 20.8-59.2 97.3 (109/112), 94.3-100 76.9 (10/13), 54.0-99.8 87.9 (109/124), 82.2-93.6
Total 333 SCVS and CCVS 31.1 (19/61), 19.5-42.8 95.2 (259/272), 92.7-97.8 59.4 (19/32), 42.4-76.4 86.0 (259/301), 82.1-90.0
a

No significant difference in test performance between subsets of paired CS and VS specimens was apparent in 2004 (P = 0.2482; McNemar's test).